Last week, UK Prime Minister Sir Keir Starmer confirmed plans to abolish NHS England (NHSE), which he referred to as an “arms-length body”. NHS England was established in 2013 during the Conservative government under David Cameron, with the intention of giving the NHS greater independence and autono
Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications, an advisor to MedTech suppliers, chair of the Urology Trade Association, and governor of the Anscombe Bioethics Centre, reminds MedTech suppliers of the looming deadline to s
Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications, an advisor to MedTech suppliers, chair of the Urology Trade Association, and governor of the Anscombe Bioethics Centre, reacts to the closure of NHS England. UK Health Secret
Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications, an advisor to MedTech suppliers, chair of the Urology Trade Association, and governor of the Anscombe Bioethics Centre, encourages engagement with the development of a new Va
Written by Barbara Harpham, Chair of the Medical Technology Group When the NHS celebrated its 75th anniversary two years ago, a “culture of innovation” was described as vital to the NHS’s longevity. The NHS does indeed have a number of successful initiatives that have allowed technology to support i
RegNav, an AI-powered compliance management platform, and Tricardia, a leading MedTech start-up consultancy, are working together to help MedTech start-ups obtain regulatory compliance for their new medical innovations. Often a highly complex and time-consuming milestone to achieve, regulatory co
Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications, an advisor to MedTech suppliers, chair of the Urology Trade Association, and governor of the Anscombe Bioethics Centre, calls on the MedTech sector to engage with the latest
Piyush Mahapatra, a consultant orthopaedic surgeon and chief innovation officer at Open Medical, considers the upcoming 10 Year Health Plan for the future of the NHS, and argues that what is needed is not a new vision, but a plan for delivery; and some radical new thinking on the role of healthcare
Leading MedTech innovation management consultancy Archetype has been appointed to drive the EU MDR (European Medical Device Regulation) approval process for LumipenPro, a medical illumination device designed to enhance precision and efficiency during aesthetic surgical procedures where visibility is
Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications, an advisor to MedTech suppliers, chair of the Urology Trade Association, and governor of the Anscombe Bioethics Centre, highlights new guidelines for assessing digital mental
Novartis UK has announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has authorised a new indication for ribociclib as an adjuvant treatment option to be used in combination with an AI for patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2
Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications, an advisor to MedTech suppliers, chair of the Urology Trade Association, and governor of the Anscombe Bioethics Centre, flags a new EU resource for biotech start-ups. The Eur
